by admin | May 12, 2017 | News
MALVERN, PA, May 10, 2017 –(BUSINESS WIRE) — Progenra, Inc. announced that it has received the Official Notice of Allowance (dated March 30, 2017) of its patent application entitled “Methods of treating cancer through the inhibition of USP7 and immune...
by admin | Dec 15, 2016 | News
MALVERN, PA, Dec 15, 2016 — (BUSINESS WIRE) — Progenra, Inc. announced a new immune-oncology drug whose mechanism differs from available cancer immunotherapies Opdivo and Keytruda. The findings, published by Progenra with Dr. Wayne Hancock, University of...
by admin | Dec 4, 2015 | Events
MALVERN, PA August 15, 2014 – Progenra, Inc. announced today that Dr. Wayne Hancock, Professor of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine has joined their Scientific Advisory Board. Dr. Hancock is a world-renowned expert in...
by admin | Dec 4, 2015 | Events
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived...
by admin | Dec 4, 2015 | Events
AACR Annual Meeting 2015 April 18-22, 2015 Pennsylvania Convention Center Philadelphia, Pennsylvania Program Committee Chairperson Lewis C. Cantley, Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College, New York, New York View Program / Itinerary...
